Publications

Found 42 results
Filters: Author is P. Wang  [Clear All Filters]
2016
L. Y. Gui, Hu, Y. L., Hou, Z. L., Wang, P., Gui, L. Y., Hu, Y. L., Hou, Z. L., and Wang, P., “Expression and clinical significance of the obesity-related gene TNFAIP9 in obese children”, vol. 15, p. -, 2016.
L. Y. Gui, Hu, Y. L., Hou, Z. L., Wang, P., Gui, L. Y., Hu, Y. L., Hou, Z. L., and Wang, P., “Expression and clinical significance of the obesity-related gene TNFAIP9 in obese children”, vol. 15, p. -, 2016.
C. L. Zou, Zheng, Y., Wang, P., Zhang, X., Wang, Y. - H., Liu, Z. Y., Feng, H., Zou, C. L., Zheng, Y., Wang, P., Zhang, X., Wang, Y. - H., Liu, Z. Y., and Feng, H., “Fine mapping and characterization of the or gene in Chinese cabbage (Brassica rapa L. ssp pekinensis)”, vol. 15, p. -, 2016.
C. L. Zou, Zheng, Y., Wang, P., Zhang, X., Wang, Y. - H., Liu, Z. Y., Feng, H., Zou, C. L., Zheng, Y., Wang, P., Zhang, X., Wang, Y. - H., Liu, Z. Y., and Feng, H., “Fine mapping and characterization of the or gene in Chinese cabbage (Brassica rapa L. ssp pekinensis)”, vol. 15, p. -, 2016.
W. Liu, Wang, J., Yin, D. X., Yang, M., Wang, P., Han, Q. S., Ma, Q. Q., Liu, J. J., Wang, J. X., Liu, W., Wang, J., Yin, D. X., Yang, M., Wang, P., Han, Q. S., Ma, Q. Q., Liu, J. J., and Wang, J. X., “Genetic diversity and structure of the threatened species Sinopodophyllum hexandrum (Royle) Ying”, vol. 15, p. -, 2016.
W. Liu, Wang, J., Yin, D. X., Yang, M., Wang, P., Han, Q. S., Ma, Q. Q., Liu, J. J., Wang, J. X., Liu, W., Wang, J., Yin, D. X., Yang, M., Wang, P., Han, Q. S., Ma, Q. Q., Liu, J. J., and Wang, J. X., “Genetic diversity and structure of the threatened species Sinopodophyllum hexandrum (Royle) Ying”, vol. 15, p. -, 2016.
L. Bu, Zhang, L. B., Mao, X., Wang, P., Bu, L., Zhang, L. B., Mao, X., and Wang, P., “GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer”, vol. 15, p. -, 2016.
L. Bu, Zhang, L. B., Mao, X., Wang, P., Bu, L., Zhang, L. B., Mao, X., and Wang, P., “GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer”, vol. 15, p. -, 2016.
J. Li, Wang, Y. Y., Tian, X. F., Nan, X., Yan, T., Wang, P., Fu, Y. L., and Wang, G. Q., “HPV genotype analysis for women in Shaanxi Province of China”, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.ACKNOWLEDGMENTSWe thank all the patients who were enrolled to this study. REFERENCESBory JP, Cucherousset J, Lorenzato M, Gabriel R, et al (2002). Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int. J. Cancer 102: 519-525. http://dx.doi.org/10.1002/ijc.10735 Clifford GM, Smith JS, Plummer M, Muñoz N, et al (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88: 63-73. http://dx.doi.org/10.1038/sj.bjc.6600688 Dai HY, Zhang XJ, et al (2013). Study on subtype age distribution and multiple infection of human papillomavirus (HPV) in Yongchuan area of Chongqion. Chongqing Med. 42: 619-621. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, et al (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect. Dis. 7: 453-459. http://dx.doi.org/10.1016/S1473-3099(07)70158-5 Doorbar J, et al (2006). Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110: 525-541. http://dx.doi.org/10.1042/CS20050369 Fan WS, Li YL, Yang YZ, Sun Z, et al (2009). Clinical analysis of human papillomavirus in paraffin-embedded cervical lesion tissues by gene chip technology. Chin. J. Nosocomiol. 19: 745-747. Garcia-Echeverria C, Sellers WR, et al (2008). Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 27: 5511-5526. http://dx.doi.org/10.1038/onc.2008.246 Jiang D, Ye JD, Zhang XP, Xu A, et al (2012). Analysis of infection of among 10000 female migrant population in Shenzhen. Chin. J. of PHM 28: 796-798. Kong DX, Qu QX, et al (2009). Expression and their correlation of COX-2 and VEGF-C in cervical cancer. J. Int. Obstet. Gynecol 36: 151-153. Lee SA, Kang D, Seo SS, Jeong JK, et al (2003). Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett. 198: 187-192. http://dx.doi.org/10.1016/S0304-3835(03)00312-4 Li C, Wu M, Wang J, Zhang S, et al (2010). A population-based study on the risks of cervical lesion and human papillomavirus infection among women in Beijing, People’s Republic of China. Cancer Epidemiol. Biomarkers Prev. 19: 2655-2664. http://dx.doi.org/10.1158/1055-9965.EPI-10-0212 Muñoz N, Bosch FX, de Sanjosé S, Herrero R, International Agency for Research on Cancer Multicenter Cervical Cancer Study Groupet al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518-527. http://dx.doi.org/10.1056/NEJMoa021641 Sandri MT, Riggio D, Salvatici M, Passerini R, et al (2009). Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J. Med. Virol. 81: 271-277. http://dx.doi.org/10.1002/jmv.21382 Wang Y, Wu ZZ, Zhou QY, et al (2010). Epidemiological characteristics of cervical human papillomavirus women in Gansu. Matern. Child Health Care China 25: 5371-5373. Woodman CB, Collins S, Winter H, Bailey A, et al (2001). Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357: 1831-1836. http://dx.doi.org/10.1016/S0140-6736(00)04956-4 Yang J, Zhou DP, Chen FX, Peng JH, et al (2012). Investigation and analysis on HPV infection status of 2497 patients with gynecological disease in Chongqing. J. Chongqing Med. Univ. 37: 347-349. Zhang JS, Geng JX, Han CR, Liu X, et al (2013). Study on human papillomavirus genetic profile in 3678 cervical cell samples of married women. Int. Lab. Med. 34: 439-441. Zhao R, Zhang WY, Wu MH, Zhang SW, et al (2009). Human papillomavirus infection in Beijing, People’s Republic of China: a population-based study. Br. J. Cancer 101: 1635-1640. http://dx.doi.org/10.1038/sj.bjc.6605351  
P. Wang, Lv, H. Y., Zhou, D. M., Zhang, E. N., Wang, P., Lv, H. Y., Zhou, D. M., and Zhang, E. N., “miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2”, vol. 15, p. -, 2016.
P. Wang, Lv, H. Y., Zhou, D. M., Zhang, E. N., Wang, P., Lv, H. Y., Zhou, D. M., and Zhang, E. N., “miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2”, vol. 15, p. -, 2016.
J. Li, Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., Fu, Y. L., Li, J., Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., Fu, Y. L., Li, J., Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., and Fu, Y. L., “Prevalence of human papillomavirus genotypes among women with cervical lesions in the Shaanxi Province of China”, vol. 15, p. -, 2016.
J. Li, Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., Fu, Y. L., Li, J., Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., Fu, Y. L., Li, J., Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., and Fu, Y. L., “Prevalence of human papillomavirus genotypes among women with cervical lesions in the Shaanxi Province of China”, vol. 15, p. -, 2016.
J. Li, Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., Fu, Y. L., Li, J., Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., Fu, Y. L., Li, J., Wang, Y. Y., Nan, X., Tian, X. F., Yan, T., Wang, P., Yin, Y., Liu, Y., Yuan, R., Wang, G. Q., and Fu, Y. L., “Prevalence of human papillomavirus genotypes among women with cervical lesions in the Shaanxi Province of China”, vol. 15, p. -, 2016.
B. Zhou, Liu, S. - Z., Li, M. - J., Chen, Z. - H., Wang, P., Cheng, D., Zhou, B., Liu, S. - Z., Li, M. - J., Chen, Z. - H., Wang, P., and Cheng, D., “Study on quality standards for Chimonanthus nitens”, vol. 15, p. -, 2016.
B. Zhou, Liu, S. - Z., Li, M. - J., Chen, Z. - H., Wang, P., Cheng, D., Zhou, B., Liu, S. - Z., Li, M. - J., Chen, Z. - H., Wang, P., and Cheng, D., “Study on quality standards for Chimonanthus nitens”, vol. 15, p. -, 2016.
2015
H. C. Qu, Zhang, W., Liu, Y. L., and Wang, P., “Association between polymorphism of β3-adrenoceptor gene and overactive bladder: a meta-analysis”, vol. 14, pp. 2495-2501, 2015.
J. J. Fan, Wang, P., Xu, X., Liu, K., Ruan, Y. Y., Zhu, Y. S., Cui, Z. H., and Zhang, L. J., “Characterization of a TIR-NBS-LRR gene associated with downy mildew resistance in grape”, vol. 14, pp. 7964-7975, 2015.
P. Wang, Huo, H. L., Wang, S. Y., Miao, Y. W., Zhang, Y. Y., Zhang, Q. L., Li, F. Q., Liu, L. X., Li, W. Z., Zeng, Y. Z., Huo, J. L., and Xiao, H., “Cloning, sequence characterization, and expression patterns of members of the porcine TSSK family”, vol. 14, pp. 14908-14919, 2015.
D. S. Chen, Qian, C. J., Ren, Q. Q., Wang, P., Yuan, J., Jiang, L., Bi, D., Zhang, Q., Wang, Y., and Kan, X. Z., “Complete mitochondrial genome of the Chinese Hwamei Garrulax canorus (Aves: Passeriformes): the first representative of the Leiothrichidae family with a duplicated control region”, vol. 14, pp. 8964-8976, 2015.
J. Li, Wang, J. S., Xie, Z. X., Wang, W. Z., Wang, L., Ma, G. Y., Li, Y. Q., and Wang, P., “Correlations among copeptin, ischemia-modified albumin, and the extent of myocardial injury in patients with acute carbon monoxide poisoning”, vol. 14, pp. 10384-10389, 2015.
K. Liu, Chen, Z., Luo, X. W., Song, G. Q., Wang, P., Li, X. D., Zhao, M., Han, X. W., Bai, Y. G., Yang, Z. L., and Feng, G., “Determination of the potential of induced pluripotent stem cells to differentiate into mouse nucleus pulposus cells in vitro”, vol. 14, pp. 12394-12405, 2015.
J. S. Wang, Qiao, L. X., Zhao, L. S., Wang, P., Guo, B. T., Liu, L. X., and Sui, J. M., “Performance of peanut mutants and their offspring generated from mixed high-energy particle field radiation and tissue culture”, vol. 14, pp. 10837-10848, 2015.
Q. Shi, Zhou, J., Wang, P., Lin, X., and Xu, Y., “Protein expression and characterization of SEP3 from Arabidopsis thaliana”, vol. 14, pp. 12529-12536, 2015.
R. Gao, Ma, D., Wang, P., Sun, J., Wang, J. S., and Fang, Q., “Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine”, vol. 14, pp. 17788-17798, 2015.
2014
Y. D. Ge, Song, P., Cao, Z. Y., Wang, P., and Zhu, G. P., “Alteration of coenzyme specificity of malate dehydrogenase from Streptomyces coelicolor A3(2) by site-directed mutagenesis”, vol. 13, pp. 5758-5766, 2014.
J. Zhang, Yao, D., Wang, P., Guan, S. Y., Ma, J., and Fu, Y. P., “Cloning and functional prediction of differentially expressed genes in the leaves of Glycine max parents and hybrids at the seedling stage”, vol. 13, pp. 5474-5483, 2014.
X. J. Li, Li, B., Huang, J. S., Shi, J. M., Wang, P., Fan, W., and Zhou, Y. L., “Effects of acrylonitrile on lymphocyte lipid rafts and RAS/RAF/MAPK/ERK signaling pathways”, vol. 13, pp. 7747-7756, 2014.
C. Y. Yuan, Zhang, C., Wang, P., Hu, S., Chang, H. P., Xiao, W. J., Lu, X. T., Jiang, S. B., Ye, J. Z., and Guo, X. H., “Genetic diversity analysis of okra (Abelmoschus esculentus L.) by inter-simple sequence repeat (ISSR) markers”, vol. 13, pp. 3165-3175, 2014.
L. M. Dong, Zhang, X. Y., Teng, H., Li, M. S., and Wang, P., “Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk”, vol. 13, pp. 9976-9985, 2014.
Y. J. Zhang, Xu, J. J., Wang, P., and Wang, J. L., “Multidrug resistance gene and its relationship to ulcerative colitis and immune status of ulcerative colitis”, vol. 13, pp. 10837-10851, 2014.
P. Wang, Gao, Y. J., Cheng, J., Kong, G. L., Wang, Y., Wu, X. Y., Zhao, Z. G., and Yuan, H. J., “Serum thyroid hormone reference intervals in the apparently healthy individuals of Zhengzhou area of China”, vol. 13, pp. 7275-7281, 2014.
P. Wang, Zhang, Y. J., Pan, X. J., Xia, X. Y., and Lv, S. Y., “Survey of attitude and knowledge of reproductive health among middle school students in Luoyang, China”, vol. 13, pp. 6168-6176, 2014.
H. C. Qu, Yan, S., Zhang, X. L., Zhu, X. W., Liu, Y. L., and Wang, P., “Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis”, vol. 13, pp. 8609-8619, 2014.
2013
W. Wei, Jiang, M., Luo, L., Li, Z., Wang, P., and Dong, W. Q., “Colorectal cancer susceptibility variants alter risk of breast cancer in a Chinese Han population”, vol. 12, pp. 6268-6274, 2013.
S. Yan, Li, Y. Z., Zhu, X. W., Liu, C. L., Wang, P., and Liu, Y. L., “HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk”, vol. 12, pp. 1561-1573, 2013.
2012
M. N. Chen, Wang, P., Zhang, J., Zhou, B. Y., Mao, Q., and Liu, Y. H., “Analysis of the role of hMLH1 hypermethylation and microsatellite instability in meningioma progression”, vol. 11, pp. 3933-3941, 2012.
Alvino E, Fernandez E and Pallini R (2000). Microsatellite instability in primary brain tumors. Neurol. Res. 22: 571-575. PMid:11045018   Baylin SB and Herman JG (2000). DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16: 168-174. http://dx.doi.org/10.1016/S0168-9525(99)01971-X   Bello MJ, Aminoso C, Lopez-Marin I, Arjona D, et al. (2004). DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol. 108: 413-421. http://dx.doi.org/10.1007/s00401-004-0911-6 PMid:15365725   Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, et al. (1998). A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58: 5248-5257. PMid:9823339   Cunningham JM, Christensen ER, Tester DJ, Kim CY, et al. (1998). Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58: 3455-3460. PMid:9699680   Dams E, Van de Kelft EJ, Martin JJ, Verlooy J, et al. (1995). Instability of microsatellites in human gliomas. Cancer Res. 55: 1547-1549. PMid:7882363   Deng G, Chen A, Hong J, Chae HS, et al. (1999). Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 59: 2029-2033. PMid:10232580   Dietmaier W, Wallinger S, Bocker T, Kullmann F, et al. (1997). Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 57: 4749-4756. PMid:9354436   Dong SM, Pang JC, Poon WS, Hu J, et al. (2001). Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J. Neuropathol. Exp. Neurol. 60: 808-816. PMid:11487055   Esteller M, Catasus L, Matias-Guiu X, Mutter GL, et al. (1999). hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am. J. Pathol. 155: 1767-1772. http://dx.doi.org/10.1016/S0002-9440(10)65492-2   Fleisher AS, Esteller M, Tamura G, Rashid A, et al. (2001). Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 20: 329-335. http://dx.doi.org/10.1038/sj.onc.1204104 PMid:11313962   Herman JG, Umar A, Polyak K, Graff JR, et al. (1998). Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 95: 6870-6875. http://dx.doi.org/10.1073/pnas.95.12.6870 PMid:9618505 PMCid:22665   Kulke MH, Thakore KS, Thomas G, Wang H, et al. (2001). Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma. Cancer 91: 1451-1457. http://dx.doi.org/10.1002/1097-0142(20010415)91:8<1451::AID-CNCR1152>3.0.CO;2-Z   Leung SY, Yuen ST, Chung LP, Chu KM, et al. (1999). hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 59: 159-164. PMid:9892201   Liu Y, Pang JC, Dong S, Mao B, et al. (2005). Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum. Pathol. 36: 416-425. http://dx.doi.org/10.1016/j.humpath.2005.02.006 PMid:15892004   Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, et al. (1993). Epidemiology of intracranial meningioma. Cancer 72: 639-648. http://dx.doi.org/10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P   Lundin DA, Blank A, Berger MS and Silber JR (1998). Microsatellite instability is infrequent in sporadic adult gliomas. Oncol. Res. 10: 421-428. PMid:10100759   Ng HK, Lau KM, Tse JY, Lo KW, et al. (1995). Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 37: 764-773. http://dx.doi.org/10.1227/00006123-199510000-00022 PMid:8559307   Perry A, Stafford SL, Scheithauer BW, Suman VJ, et al. (1997). Meningioma grading: an analysis of histologic parameters. Am. J. Surg. Pathol. 21: 1455-1465. http://dx.doi.org/10.1097/00000478-199712000-00008 PMid:9414189   Perry A, Scheithauer BW, Stafford SL, Lohse CM, et al. (1999). "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85: 2046-2056. http://dx.doi.org/10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M   Perry A, Giannini C, Raghavan R, Scheithauer BW, et al. (2001). Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J. Neuropathol. Exp. Neurol. 60: 994-1003. PMid:11589430   Pykett MJ, Murphy M, Harnish PR and George DL (1994). Identification of a microsatellite instability phenotype in meningiomas. Cancer Res. 54: 6340-6343. PMid:7987826   Radner H, Blumcke I, Reifenberger G and Wiestler OD (2002). The new WHO classification of tumors of the nervous system 2000. Pathology and genetics. Pathologe 23: 260-283. http://dx.doi.org/10.1007/s00292-002-0530-8 PMid:12185780   Salvesen HB, MacDonald N, Ryan A, Iversen OE, et al. (2000). Methylation of hMLH1 in a population-based series of endometrial carcinomas. Clin. Cancer Res. 6: 3607-3613. PMid:10999752   Sambrook J, Fritsh EF and Maniatis T (1989). Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York.   Simpkins SB, Bocker T, Swisher EM, Mutch DG, et al. (1999). MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum. Mol. Genet. 8: 661-666. http://dx.doi.org/10.1093/hmg/8.4.661 PMid:10072435   Skotheim RI, Diep CB, Kraggerud SM, Jakobsen KS, et al. (2001). Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA. Cancer Genet. Cytogenet. 127: 64-70. http://dx.doi.org/10.1016/S0165-4608(00)00433-7   Sobrido MJ, Pereira CR, Barros F, Forteza J, et al. (2000). Low frequency of replication errors in primary nervous system tumours. J. Neurol. Neurosurg. Psychiatry 69: 369-375. http://dx.doi.org/10.1136/jnnp.69.3.369 PMid:10945812 PMCid:1737093   Thibodeau SN, Bren G and Schaid D (1993). Microsatellite instability in cancer of the proximal colon. Science 260: 816- 819. http://dx.doi.org/10.1126/science.8484122 PMid:8484122   Ueki K, Wen-Bin C, Narita Y, Asai A, et al. (1999). Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res. 59: 5995-5998. PMid:10606247   Veigl ML, Kasturi L, Olechnowicz J, Ma AH, et al. (1998). Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl. Acad. Sci. U. S. A. 95: 8698-8702. http://dx.doi.org/10.1073/pnas.95.15.8698 PMid:9671741 PMCid:21139   Wellenreuther R, Kraus JA, Lenartz D, Menon AG, et al. (1995). Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am. J. Pathol. 146: 827-832. PMid:7717450 PMCid:1869258   Wirtz HC, Müller W, Noguchi T, Scheven M, et al. (1998). Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin. Cancer Res. 4: 1749-1754. PMid:9676851   Zhu J, Guo SZ, Beggs AH, Maruyama T, et al. (1996). Microsatellite instability analysis of primary human brain tumors. Oncogene 12: 1417-1423. PMid:8622857
J. Y. Zheng, Wang, H., Chen, X. X., Wang, P., Gao, P., Li, X. N., and Zhu, G. P., “Microsatellite markers for assessing genetic diversity of the medicinal plant Paris polyphylla var. chinensis (Trilliaceae)”, vol. 11, pp. 1975-1980, 2012.
Belkhir KP, Borsa P, Chikhi L, Raufaste N, et al. (2001). GENETIX, Logiciel Sous WindowsTM Pour la Génétique des Populations. Laboratoire Génome, Populations, Interactions CNRS UMR 5000. Université de Montpellier II, Montpellier.   Bloor PA, Barker FS, Watts PC, Noyes HA, et al. (2001). Microsatellite Libraries by Enrichment. Available at [http://www.genomics.liv.ac.uk/animal/MICROSAT.PDF]. Accessed January 2002.   Cabral PD, Soares TC, Lima AB, de Miranda FD, et al. (2011). Genetic diversity in local and commercial dry bean (Phaseolus vulgaris) accessions based on microsatellite markers. Genet. Mol. Res. 10: 140-149. http://dx.doi.org/10.4238/vol10-1gmr993 PMid:21308655   Chakraborty R, Kimmel M, Stivers DN, Davison LJ, et al. (1997). Relative mutation rates at di-, tri-, and tetranucleotide microsatellite loci. Proc. Natl. Acad. Sci. U. S. A. 94: 1041-1046. http://dx.doi.org/10.1073/pnas.94.3.1041 PMid:9023379 PMCid:19636   Demir K, Bakir M, Sarikamis G and Acunalp S (2010). Genetic diversity of eggplant (Solanum melongena) germplasm from Turkey assessed by SSR and RAPD markers. Genet. Mol. Res. 9: 1568-1576. http://dx.doi.org/10.4238/vol9-3gmr878 PMid:20714999   Doyle JJ and Doyle JL (1987). A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochem. Bull. 19: 11-15.   Ellegren H (2004). Microsatellites: simple sequences with complex evolution. Nat. Rev. Genet. 5: 435-445. http://dx.doi.org/10.1038/nrg1348 PMid:15153996   Goncalves LS, Rodrigues R, do Amaral Junior AT, Karasawa M, et al. (2009). Heirloom tomato gene bank: assessing genetic divergence based on morphological, agronomic and molecular data using a Ward-modified location model. Genet. Mol. Res. 8: 364-374. http://dx.doi.org/10.4238/vol8-1gmr549 PMid:19440972   Ji S, Zhou TS and Chang CJ (2001). Determination of anti tumor cytotoxic active substance gracillin in Rhizoma Paridis and yunnan white. Chin. Tradit. Patent Med. 23: 212-215.   Leal AA, Mangolin CA, do Amaral ATJ, Goncalves LS, et al. (2010). Efficiency of RAPD versus SSR markers for determining genetic diversity among popcorn lines. Genet. Mol. Res. 9: 9-18. http://dx.doi.org/10.4238/vol9-1gmr692 PMid:20082266   Li H (1986). A study on the taxonomy of the genus Paris L. Bull. Bot. Res. 6: 109-144.   Li H, Yang X, Liang H, Wei Z, et al. (1998). The Genus Paris (Trilliaceae). Science Press, Beijing.   Liang SY and Soukup VG (2000). Paris L. In: Flora of China (Wu ZY and Raven PH, eds.). Vol. 24. Science Press, Beijing, Missouri Botanical Garden Press, St. Louis.   Nei M, Maruyama T and Chakraborty R (1975). The bottleneck effect and genetic variability in populations. Evolution 29: 1-10. http://dx.doi.org/10.2307/2407137   Oliveira EC, Amaral Junior AT, Goncalves LS, Pena GF, et al. (2010). Optimizing the efficiency of the touchdown technique for detecting inter-simple sequence repeat markers in corn (Zea mays). Genet. Mol. Res. 9: 835-842. http://dx.doi.org/10.4238/vol9-2gmr767 PMid:20449816   R aymond M and Rousset F (1995). GENEPOP (Version 1.2): population genetics software for exact tests and ecumenicism. J. Hered. 86: 248-249.   Roa AC, Chavarriaga-Aguirre P, Duque MC, Maya MM, et al. (2000). Cross-species amplification of cassava (Manihot esculenta) (Euphorbiaceae) microsatellites: allelic polymorphism and degree of relationship. Am. J. Bot. 87: 1647-1655. http://dx.doi.org/10.2307/2656741 PMid:11080115   Schlötterer C (2004). The evolution of molecular markers - just a matter of fashion? Nat. Rev. Genet. 5: 63-69. http://dx.doi.org/10.1038/nrg1249 PMid:14666112   Sharma PC, Grover A and Kahl G (2007). Mining microsatellites in eukaryotic genomes. Trends Biotechnol. 25: 490-498. http://dx.doi.org/10.1016/j.tibtech.2007.07.013 PMid:17945369   van Oosterhout C, Hutchinson WF, Wills DPM and Shipley P (2004). MICRO-CHECKER: software for identifying and correcting genotyping errors in microsatellite data. Mol. Ecol. Notes 4: 535-538. http://dx.doi.org/10.1111/j.1471-8286.2004.00684.x   Vieira EA, Carvalho FIF, Bertan I, Kopp MM, et al. (2007). Association between genetic distances in wheat (Triticum aestivum L.) as estimated by AFLP and morphological markers. Genet. Mol. Biol. 30: 392-399. http://dx.doi.org/10.1590/S1415-47572007000300016   Wu SS, Gao WY, Duan HQ and Jia W (2004). Advances in studies on chemical constituents and pharmacological activities of Rhizoma paridis. Chin. Tradit. Herb. Drugs. 3: 344-347.
S. Yan, Li, Y. Z., Zhu, J. W., Liu, C. L., Wang, P., and Liu, Y. L., “Role of CASP-10 gene polymorphisms in cancer susceptibility: a HuGE review and meta-analysis”, vol. 11, pp. 3998-4007, 2012.
Alison MR and Sarraf CE (1992). Apoptosis: a gene-directed programme of cell death. J. R. Coll. Physicians Lond. 26: 25-35. PMid:1315390   Boatright KM and Salvesen GS (2003). Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15: 725-731. http://dx.doi.org/10.1016/j.ceb.2003.10.009 PMid:14644197   Doonan F and Cotter TG (2008). Morphological assessment of apoptosis. Methods 44: 200-204. http://dx.doi.org/10.1016/j.ymeth.2007.11.006 PMid:18314050   Frank B, Hemminki K, Wappenschmidt B, Meindl A, et al. (2006). Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27: 606-609. http://dx.doi.org/10.1093/carcin/bgi248 PMid:16251207   Gaudet MM, Milne RL, Cox A, Camp NJ, et al. (2009). Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol. Biomarkers Prev. 18: 1610-1616. http://dx.doi.org/10.1158/1055-9965.EPI-08-0745 PMid:19423537 PMCid:2737177   Ghavami S, Hashemi M, Ande SR, Yeganeh B, et al. (2009). Apoptosis and cancer: mutations within caspase genes. J. Med. Genet. 46: 497-510. http://dx.doi.org/10.1136/jmg.2009.066944 PMid:19505876   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919   Hosgood HD, III, Baris D, Zhang Y, Zhu Y, et al. (2008). Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol. Oncol. 26: 148-151. http://dx.doi.org/10.1002/hon.852 PMid:18381704 PMCid:2586415   Kim MS, Oh JE, Min CK, Lee S, et al. (2009). Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas. Pathology 41: 484-487. http://dx.doi.org/10.1080/00313020903041143 PMid:19900088   Kumar S (2004). Measurement of caspase activity in cells undergoing apoptosis. Methods Mol. Biol. 282: 19-30. PMid:15105554   Lan Q, Zheng T, Chanock S, Zhang Y, et al. (2007). Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 28: 823-827. http://dx.doi.org/10.1093/carcin/bgl196 PMid:17071630   Li C, Zhao H, Hu Z, Liu Z, et al. (2008). Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum. Mutat. 29: 1443-1451. http://dx.doi.org/10.1002/humu.20803 PMid:18563783 PMCid:2937220   MacPherson G, Healey CS, Teare MD, Balasubramanian SP, et al. (2004). Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl. Cancer Inst. 96: 1866-1869. http://dx.doi.org/10.1093/jnci/dji001 PMid:15601643   Nicholson DW (1996). ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol. 14: 297-301. http://dx.doi.org/10.1038/nbt0396-297 PMid:9630889   Nicholson DW and Thornberry NA (1997). Caspases: killer proteases. Trends Biochem. Sci. 22: 299-306. http://dx.doi.org/10.1016/S0968-0004(97)01085-2   Niles AL, Moravec RA and Riss TL (2008). Caspase activity assays. Methods Mol. Biol. 414: 137-150. PMid:18175817   Oh JE, Kim MS, Ahn CH, Kim SS, et al. (2010). Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas. Pathology 42: 73-76. http://dx.doi.org/10.3109/00313020903434371 PMid:20025484   Park WS, Lee JH, Shin MS, Park JY, et al. (2002). Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21: 2919-2925. http://dx.doi.org/10.1038/sj.onc.1205394 PMid:11973654   Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. http://dx.doi.org/10.1001/jama.295.6.676 PMid:16467236   Rupinder SK, Gurpreet AK and Manjeet S (2007). Cell suicide and caspases. Vascul. Pharmacol. 46: 383-393. http://dx.doi.org/10.1016/j.vph.2007.01.006 PMid:17382599   Shin MS, Kim HS, Kang CS, Park WS, et al. (2002). Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99: 4094-4099. http://dx.doi.org/10.1182/blood.V99.11.4094 PMid:12010812   Ulybina YM, Kuligina ES, Mitiushkina NV, Rozanov ME, et al. (2009). Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett. 278: 183-191. http://dx.doi.org/10.1016/j.canlet.2009.01.012 PMid:19203830   von Elm E, Altman DG, Egger M, Pocock SJ, et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18: 800-804. http://dx.doi.org/10.1097/EDE.0b013e3181577654 PMid:18049194   Wang J, Chun HJ, Wong W, Spencer DM, et al. (2001). Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 98: 13884-13888. http://dx.doi.org/10.1073/pnas.241358198 PMid:11717445 PMCid:61136   Ye YF (2004). Polymorphisms of Caspase-8, -10 Genes and Their Relationship with Pathogenesis of Non-Hodgkin lymphoma. Master's thesis, Zhejiang University School of Medicine, Zhejiang.   Zhang L, Liu JL, Zhang YJ and Wang H (2011). Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin. Exp. Rheumatol. 29: 285-292. PMid:21418777   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093
2011
P. Wang, Ni, R. Y., Chen, M. N., Mou, K. J., Mao, Q., and Liu, Y. H., “Expression of aquaporin-4 in human supratentorial meningiomas with peritumoral brain edema and correlation of VEGF with edema formation”, vol. 10, pp. 2165-2171, 2011.
Bitzer M, Wockel L, Morgalla M, Keller C, et al. (1997a). Peritumoural brain oedema in intracranial meningiomas: influence of tumour size, location and histology. Acta Neurochir. 139: 1136-1142. http://dx.doi.org/10.1007/BF01410973 PMid:9479419 Bitzer M, Wockel L, Luft AR, Wakhloo AK, et al. (1997b). The importance of pial blood supply to the development of peritumoral brain edema in meningiomas. J. Neurosurg. 87: 368-373. http://dx.doi.org/10.3171/jns.1997.87.3.0368 PMid:9285600 Bitzer M, Opitz H, Popp J, Morgalla M, et al. (1998). Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir. 140: 333-340. http://dx.doi.org/10.1007/s007010050106 PMid:9689324 Campbell BA, Jhamb A, Maguire JA, Toyota B, et al. (2009). Meningiomas in 2009: controversies and future challenges. Am. J. Clin. Oncol. 32: 73-85. http://dx.doi.org/10.1097/COC.0b013e31816fc920 PMid:19194129 Ding YS, Wang HD, Tang K, Hu ZG, et al. (2008). Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas. Ann. Clin. Lab. Sci. 38: 344-351. PMid:18988927 Goldman CK, Bharara S, Palmer CA, Vitek J, et al. (1997). Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40: 1269-1277. http://dx.doi.org/10.1097/00006123-199706000-00029 PMid:9179901 Ide M, Jimbo M, Kubo O, Yamamoto M, et al. (1992). Peritumoral brain edema associated with meningioma-histological study of the tumor margin and surrounding brain. Neurol. Med. Chir. 32: 65-71. http://dx.doi.org/10.2176/nmc.32.65 PMid:1376862 Jung JS, Bhat RV, Preston GM, Guggino WB, et al. (1994). Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc. Natl. Acad. Sci. U. S. A. 91: 13052-13056. http://dx.doi.org/10.1073/pnas.91.26.13052 Kalkanis SN, Carroll RS, Zhang J, Zamani AA, et al. (1996). Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J. Neurosurg. 85: 1095-1101. http://dx.doi.org/10.3171/jns.1996.85.6.1095 PMid:8929501 Klatzo I (1994). Evolution of brain edema concepts. Acta Neurochir. Suppl. 60: 3-6. Machein MR and Plate KH (2000). VEGF in brain tumors. J. Neurooncol. 50: 109-120. http://dx.doi.org/10.1023/A:1006416003964 PMid:11245271 Ng WH, Hy JW, Tan WL, Liew D, et al. (2009). Aquaporin-4 expression is increased in edematous meningiomas. J. Clin. Neurosci. 16: 441-443. http://dx.doi.org/10.1016/j.jocn.2008.04.028 PMid:19153045 Otsuka S, Tamiya T, Ono Y, Michiue H, et al. (2004). The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas. J. Neurooncol. 70: 349-357. http://dx.doi.org/10.1007/s11060-004-9164-4 PMid:15662977 Provias J, Claffey K, delAguila L, Lau N, et al. (1997). Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40: 1016-1026. http://dx.doi.org/10.1097/00006123-199705000-00027 PMid:9149260 Saadoun S, Papadopoulos MC, Davies DC, Krishna S, et al. (2002). Aquaporin-4 expression is increased in oedematous human brain tumours. J. Neurol. Neurosurg. Psychiatry 72: 262-265. http://dx.doi.org/10.1136/jnnp.72.2.262 PMid:50411 Tait MJ, Saadoun S, Bell BA and Papadopoulos MC (2008). Water movements in the brain: role of aquaporins. Trends Neurosci. 31: 37-43. http://dx.doi.org/10.1016/j.tins.2007.11.003 PMid:18054802 Yoshioka H, Hama S, Taniguchi E, Sugiyama K, et al. (1999). Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer 85: 936-944. http://dx.doi.org/10.1002/(SICI)1097-0142(19990215)85:4<936::AID-CNCR23>3.0.CO;2-J
M. S. Li, Liu, J. L., Wu, Y., Wang, P., and Teng, H., “Meta-analysis demonstrates no association between p53 codon 72 polymorphism and prostate cancer risk”, vol. 10, pp. 2924-2933, 2011.
Coughlin SS and Hall IJ (2002). A review of genetic polymorphisms and prostate cancer risk. Ann. Epidemiol. 12: 182- 196. http://dx.doi.org/10.1016/S1047-2797(01)00310-6 Guimaraes DP and Hainaut P (2002). TP53: a key gene in human cancer. Biochimie 84: 83-93. http://dx.doi.org/10.1016/S0300-9084(01)01356-6 Henner WD, Evans AJ, Hough KM, Harris EL, et al. (2001). Association of codon 72 polymorphism of p53 with lower prostate cancer risk. Prostate 49: 263-266. http://dx.doi.org/10.1002/pros.10021 PMid:11746272 Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919 Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991). p53 mutations in human cancers. Science 253: 49-53. http://dx.doi.org/10.1126/science.1905840 PMid:1905840 Hsing AW and Chokkalingam AP (2006). Prostate cancer epidemiology. Front. Biosci. 11: 1388-1413. http://dx.doi.org/10.2741/1891 PMid:16368524 Huang SP, Wu WJ, Chang WS, Wu MT, et al. (2004). p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Canc. Epidemiol. Biomarkers Prev. 13: 2217-2224. PMid:15598783 Jemal A, Siegel R, Xu J and Ward E (2010). Cancer statistics, 2010. CA Cancer J. Clin. 60: 277-300. http://dx.doi.org/10.3322/caac.20073 PMid:20610543 Katkoori VR, Jia X, Shanmugam C, Wan W, et al. (2009). Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin. Cancer Res. 15: 2406-2416. http://dx.doi.org/10.1158/1078-0432.CCR-08-1719 PMid:19339276 Klug SJ, Ressing M, Koenig J, Abba MC, et al. (2009). TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 10: 772-784. http://dx.doi.org/10.1016/S1470-2045(09)70187-1 Leiros GJ, Galliano SR, Sember ME, Kahn T, et al. (2005). Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol. 5: 15. http://dx.doi.org/10.1186/1471-2490-5-15 PMid:16307686 PMCid:1314892 Lesko SM, Rosenberg L and Shapiro S (1996). Family history and prostate cancer risk. Am. J. Epidemiol. 144: 1041-1047. PMid:8942435 Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell 88: 323-331. http://dx.doi.org/10.1016/S0092-8674(00)81871-1 Levine AJ, Momand J and Finlay CA (1991). The p53 tumour suppressor gene. Nature 351: 453-456. http://dx.doi.org/10.1038/351453a0 PMid:2046748 Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, et al. (2000). Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343: 78-85. http://dx.doi.org/10.1056/NEJM200007133430201 PMid:10891514 Mechanic LE, Bowman ED, Welsh JA, Khan MA, et al. (2007). Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol. Biomarkers Prev. 16: 214-222. http://dx.doi.org/10.1158/1055-9965.EPI-06-0790 Pegoraro RJ, Moodley M, Rom L, Chetty R, et al. (2003). P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans. Int. J. Gynecol. Cancer 13: 444-449. http://dx.doi.org/10.1046/j.1525-1438.2003.13333.x PMid:12911720 Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. http://dx.doi.org/10.1001/jama.295.6.676 PMid:16467236 Quinones LA, Irarrazabal CE, Rojas CR, Orellana CE, et al. (2006). Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study. Asian J. Androl. 8: 349-355. http://dx.doi.org/10.1111/j.1745-7262.2006.00135.x PMid:16625286 Ricks-Santi L, Mason T, Apprey V, Ahaghotu C, et al. (2010). p53 Pro72Arg polymorphism and prostate cancer in men of African descent. Prostate 70: 1739-1745. PMid:20593380 PMCid:3057117 Shepherd T, Tolbert D, Benedetti J, Macdonald J, et al. (2000). Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 118: 1039-1044. http://dx.doi.org/10.1016/S0016-5085(00)70356-8 Suzuki K, Matsui H, Ohtake N, Nakata S, et al. (2003). A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. J. Biomed. Sci. 10: 430-435. http://dx.doi.org/10.1007/BF02256434 PMid:12824702 Tsai MH, Lin CD, Hsieh YY, Chang FC, et al. (2002). Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope 112: 116-119. http://dx.doi.org/10.1097/00005537-200201000-00020 PMid:11802048 Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, et al. (2007). STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835. http://dx.doi.org/10.1097/EDE.0b013e3181577511 PMid:18049195 Viechtbauer W (2007). Confidence intervals for the amount of heterogeneity in meta-analysis. Stat. Med. 26: 37-52. http://dx.doi.org/10.1002/sim.2514 PMid:16463355 Wang YC, Chen CY, Chen SK, Chang YY, et al. (1999). p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin. Cancer Res. 5: 129-134. PMid:9918210 Wu HC, Chang CH, Chen HY, Tsai FJ, et al. (2004). p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urol. Int. 73: 41-46. http://dx.doi.org/10.1159/000078803 PMid:15263792 Wu WJ, Kakehi Y, Habuchi T, Kinoshita H, et al. (1995). Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers. Jpn. J. Cancer Res. 86: 730-736. http://dx.doi.org/10.1111/j.1349-7006.1995.tb02461.x Zhou Y, Li N, Zhuang W, Liu GJ, et al. (2007). P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int. J. Cancer 121: 1481-1486. http://dx.doi.org/10.1002/ijc.22833 PMid:17546594 Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093
R. H. Wu, Wang, P., Yang, L., Li, Y., Liu, Y., and Liu, M., “A potential indicator of denervated muscle atrophy: the ratio of myostatin to follistatin in peripheral blood”, vol. 10, pp. 3914-3923, 2011.
Amthor H, Nicholas G, McKinnell I, Kemp CF, et al. (2004). Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev. Biol. 270: 19-30. http://dx.doi.org/10.1016/j.ydbio.2004.01.046 PMid:15136138   Diel P, Schiffer T, Geisler S, Hertrampf T, et al. (2010). Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive immuno PCR. Mol. Cell Endocrinol. 330: 1-9. http://dx.doi.org/10.1016/j.mce.2010.08.015 PMid:20801187   Dinh P, Hazel A, Palispis W, Suryadevara S, et al. (2009). Functional assessment after sciatic nerve injury in a rat model. Microsurgery 29: 644-649. http://dx.doi.org/10.1002/micr.20685 PMid:19653327   Gilson H, Schakman O, Kalista S, Lause P, et al. (2009). Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am. J. Physiol. Endocrinol. Metab. 297: E157-E164. http://dx.doi.org/10.1152/ajpendo.00193.2009 PMid:19435857   Hill JJ, Davies MV, Pearson AA, Wang JH, et al. (2002). The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J. Biol. Chem. 277: 40735-40741. http://dx.doi.org/10.1074/jbc.M206379200 PMid:12194980   Lakshman KM, Bhasin S, Corcoran C, Collins-Racie LA, et al. (2009). Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration. Mol. Cell Endocrinol. 302: 26-32. http://dx.doi.org/10.1016/j.mce.2008.12.019 PMid:19356623   Lee SJ (2010). Extracellular regulation of myostatin: A molecular rheostat for muscle mass. Immunol. Endocr. Metab. Agents Med. Chem. 10: 183-194. http://dx.doi.org/10.2174/187152210793663748 PMid:21423813 PMCid:3060380   Lee SJ and McPherron AC (2001). Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U. S. A. 98: 9306-9311. http://dx.doi.org/10.1073/pnas.151270098 PMid:11459935 PMCid:55416   Lee SJ, Lee YS, Zimmers TA, Soleimani A, et al. (2010). Regulation of muscle mass by follistatin and activins. Mol. Endocrinol. 24: 1998-2008. http://dx.doi.org/10.1210/me.2010-0127 PMid:20810712 PMCid:2954636   Liu M, Zhang D, Shao C, Liu J, et al. (2007). Expression pattern of myostatin in gastrocnemius muscle of rats after sciatic nerve crush injury. Muscle Nerve 35: 649-656. http://dx.doi.org/10.1002/mus.20749 PMid:17326119   Matzuk MM, Lu N, Vogel H, Sellheyer K, et al. (1995). Multiple defects and perinatal death in mice deficient in follistatin. Nature 374: 360-363. http://dx.doi.org/10.1038/374360a0 PMid:7885475   McPherron AC, Lawler AM and Lee SJ (1997). Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90. http://dx.doi.org/10.1038/387083a0 PMid:9139826   Rodino-Klapac LR, Haidet AM, Kota J, Handy C, et al. (2009). Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 39: 283-296. http://dx.doi.org/10.1002/mus.21244 PMid:19208403 PMCid:2717722   Thies RS, Chen T, Davies MV, Tomkinson KN, et al. (2001). GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18: 251-259. http://dx.doi.org/10.3109/08977190109029114 PMid:11519824   Thompson TB, Lerch TF, Cook RW, Woodruff TK, et al. (2005). The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Dev. Cell 9: 535-543. http://dx.doi.org/10.1016/j.devcel.2005.09.008 PMid:16198295   Ueno N, Ling N, Ying SY, Esch F, et al. (1987). Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc. Natl. Acad. Sci. U. S. A. 84: 8282-8286. http://dx.doi.org/10.1073/pnas.84.23.8282 PMid:3120188 PMCid:299526   Wallimann T, Wyss M, Brdiczka D, Nicolay K, et al. (1992). Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 281: 21-40. PMid:1731757 PMCid:1130636   Whittemore LA, Song K, Li X, Aghajanian J, et al. (2003). Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem. Biophys. Res. Commun. 300: 965-971. http://dx.doi.org/10.1016/S0006-291X(02)02953-4   Wolfman NM, McPherron AC, Pappano WN, Davies MV, et al. (2003). Activation of latent myostatin by the BMP-1/ tolloid family of metalloproteinases. Proc. Natl. Acad. Sci. U. S. A. 100: 15842-15846. http://dx.doi.org/10.1073/pnas.2534946100 PMid:14671324 PMCid:307655   Zhang D, Liu M, Ding F and Gu X (2006). Expression of myostatin RNA transcript and protein in gastrocnemius muscle of rats after sciatic nerve resection. J. Muscle Res. Cell Motil. 27: 37-44. http://dx.doi.org/10.1007/s10974-005-9050-5 PMid:16450055